These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1514 related articles for article (PubMed ID: 26564819)

  • 21. Donor and recipient cell surface colony stimulating factor-1 promote neointimal formation in transplant-associated arteriosclerosis.
    Hiroyasu S; Chinnasamy P; Hou R; Hotchkiss K; Casimiro I; Dai XM; Stanley ER; Sibinga NE
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):87-95. PubMed ID: 23117661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells.
    Gadang V; Konaniah E; Hui DY; Jaeschke A
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1429-36. PubMed ID: 24790140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
    Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
    Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
    Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.
    Zhou LJ; Chen XY; Liu SP; Zhang LL; Xu YN; Mu PW; Geng DF; Tan Z
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
    J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calreticulin Regulates Neointima Formation and Collagen Deposition following Carotid Artery Ligation.
    Zimmerman KA; Xing D; Pallero MA; Lu A; Ikawa M; Black L; Hoyt KL; Kabarowski JH; Michalak M; Murphy-Ullrich JE
    J Vasc Res; 2015; 52(5):306-20. PubMed ID: 26910059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice.
    Hubert A; Bochenek ML; Schütz E; Gogiraju R; Münzel T; Schäfer K
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1683-1697. PubMed ID: 28705795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia.
    Greig FH; Kennedy S; Gibson G; Ramos JW; Nixon GF
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28893763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.
    Lavin B; Gómez M; Pello OM; Castejon B; Piedras MJ; Saura M; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1739-46. PubMed ID: 24925976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
    Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
    PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
    Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
    Serrano RL; Yu W; Graham RM; Bryan RL; Terkeltaub R
    PLoS One; 2019; 14(4):e0212235. PubMed ID: 30943188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration.
    Williams H; Mill CA; Monk BA; Hulin-Curtis S; Johnson JL; George SJ
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1417-24. PubMed ID: 27199447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.